Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Canadafan,

<< Previous

Bullboard Posts

Next >>

Comment by BioBillyon Dec 07, 2020 4:44pm

189 Views

Post# 32053124

RE:RE:RE:RE:RE:RE:RE:Canadafan,

Very normal market conditions as I can see. Some people taking profits. Looik at NIO. Hit a high of $57 in November. Went down to $39 last week. Up to $45 today. Different stock in a different class but all stocks move up and down. I wouldn't be the least concerned about these small movements in ONC. Cheers.

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year